Видео ютуба по тегу Irst Irccs

Nanotechnology against cancer: CdO-TR researchers develop a promising new drug
Nanotechnology against cancer: CdO-TR researchers develop a promising new drug
EVENT/ State of play of the European beating cancer plan
EVENT/ State of play of the European beating cancer plan
Mieloma multiplo, quali sono le novità più importanti del congresso europeo di ematologia (EHA)?
Mieloma multiplo, quali sono le novità più importanti del congresso europeo di ematologia (EHA)?
IRST IRCCS Presentation
IRST IRCCS Presentation
Combining whole body-MRI & PET-CT to improve the diagnosis, stratification, and treatment of myeloma
Combining whole body-MRI & PET-CT to improve the diagnosis, stratification, and treatment of myeloma
Updates on myeloma research from IMS 2025: advances in frontline and R/R treatment
Updates on myeloma research from IMS 2025: advances in frontline and R/R treatment
The importance of risk stratification and redefining high-risk in myeloma
The importance of risk stratification and redefining high-risk in myeloma
The role of PET-CT plus whole-body MRI for staging patients with high-risk smoldering myeloma
The role of PET-CT plus whole-body MRI for staging patients with high-risk smoldering myeloma
Redefining risk stratification in multiple myeloma
Redefining risk stratification in multiple myeloma
TP53 in Myeloid Leukemias: Targeting the Guardian of the Genome
TP53 in Myeloid Leukemias: Targeting the Guardian of the Genome
A novel model being used to investigate thrombo-inflammation in MPNs
A novel model being used to investigate thrombo-inflammation in MPNs
INTERVISTA SIMONA presso IRST di Meldola (FC)
INTERVISTA SIMONA presso IRST di Meldola (FC)
Come si tratta il mieloma multiplo? Italia e Stati Uniti a confronto
Come si tratta il mieloma multiplo? Italia e Stati Uniti a confronto
Insights into disease-modifying agents being explored in MPNs
Insights into disease-modifying agents being explored in MPNs
Anti-CD38–based quadruplet regimens for patients with transplant-ineligible multiple myeloma
Anti-CD38–based quadruplet regimens for patients with transplant-ineligible multiple myeloma
Potential treatment strategies for patients with penta-class refractory multiple myeloma
Potential treatment strategies for patients with penta-class refractory multiple myeloma
Understanding aberrant signaling pathways to prevent resistance to JAK2 inhibitors in MPNs
Understanding aberrant signaling pathways to prevent resistance to JAK2 inhibitors in MPNs
The management of smoldering myeloma: key trials and the importance of risk stratification
The management of smoldering myeloma: key trials and the importance of risk stratification